Scientific Library
- Acute Coronary Syndrom
- ASCVD Prevention
- Bifurcation Stenting
- Cardio-Oncology
- Congestive Heart Failure
- DAPT Duration
- Drug Coated Balloon
- Fractional Flow Reserve
- IVUS Guidance
- Optical Coherence Tomography
- Pulmonary Hypertension
- Rotational Atherectomy
- Shear Stress
- Stenting Left Main
- Transcatheter Aortic Valve Replacement
- Percutaneous LAA Occlusion
- Mitral/Tricuspid Valvular Disease
- Other Relevant Articles
-
Diagnostic accuracy of fractional flow reserve from anatomic CT angiographyMin JK, Leipsic J, Pencina MJ et al. -
Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplastyPijls NH, van Son JA, Kirkeeide RL et al.
-
Machine Learning Approaches in Cardiovascular ImagingHenglin M, Stein G, Hushcha PV et al.
-
Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOWKoo BK, Erglis A, Doh JH et al.
-
Long-term Variations of FFR and iFR After Transcatheter Aortic Valve ImplantationR Scarsini, M Lunardi, F Ribichini et al.
-
Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps)Nørgaard BL, Leipsic J, NXT Trial Study Group.
-
Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization)Lønborg J, Engstrøm T, DANAMI 3-PRIMULTI Investigators et al.
-
Five-Year Outcomes with PCI Guided by Fractional Flow ReserveXaplanteris P, Fournier S, FAME 2 Trial Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
